RESULTS: In IVIG-treated patients, a clinically meaningful improvement in QMG Score for Disease Severity was observed at day 14 and persisted at day 28.
结果：使用IVIG的患者，重症肌无力疾病严重程度评分在14天出现有意义的改善，并持续改善至28天。
The Quantitative Myasthenia Gravis (QMG) Score for Disease Severity, a validated clinical composite scale, was calculated by a masked observer at baseline and days 14 and 28.
被设盲的观察者通过定量重症肌无力疾病严重程度评分系统这一被认可的复合标准来计算基础水平和14天、28天的评分。
ConclusionIBMP-10 score is a simple, rapid and convenient method easy to memorize and use in predicting the disease severity and prognosis in patients with VAP.
结论在评估VAP病情危重程度及预测预后方面，IBMP - 10评分过程简单快速、方便记忆和使用，更具有临床实用性。
The model for end-stage liver disease (MELD) score is a prospectively developed and validated scale for the severity of end-stage liver disease.
终末期肝病模型（MELD）是目前被广泛认可的评估终末期肝病严重程度的评分体系。
The model for end-stage liver disease (MELD) score is a prospectively developed and validated scale for the severity of end-stage liver disease.
终末期肝病模型（MELD）是目前被广泛认可的评估终末期肝病严重程度的评分体系。
应用推荐